Telemetry Investments, L.L.C. Scynexis Inc Transaction History

Telemetry Investments, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.77 - $3.87 $171,690 - $375,390	-97,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.56 - $6.66 $71,200 - $133,200	20,000 Added 25.97%	97,000 $379,000
Q4 2021 Feb 14, 2022	SELL	$4.94 - $7.69 $314,974 - $490,314	-63,760 Reduced 45.3%	77,000 $470,000
Q3 2021 Nov 15, 2021	BUY	$5.3 - $7.89 $37,110 - $55,245	7,002 Added 5.23%	140,760 $746,000
Q2 2021 Aug 16, 2021	BUY	$6.5 - $9.97 $276,172 - $423,605	42,488 Added 46.55%	133,758 $984,000
Q1 2021 May 17, 2021	BUY	$6.93 - $9.63 $372,626 - $517,805	53,770 Added 143.39%	91,270 $725,000
Q4 2020 Feb 16, 2021	BUY	$4.28 - $7.87 $160,500 - $295,125	37,500 New	37,500 $287,000

14.5M

34K

Ticker SCYX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 32,651,800
Market Cap $48.7M
Description
SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...

Get notified when there are updates to the investment portfolio of Telemetry Investments, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Telemetry Investments, L.L.C. with notifications on news.